SurvBenchmark

SurvBenchmark evaluates survival analysis methods across censored omics and clinical datasets to quantify and compare model predictability, stability, flexibility, and computational efficiency.


Key Features:

  • Diverse Model Evaluation: Evaluates a wide array of survival models, including the Cox model and machine-learning–based survival approaches.
  • Multi-Metric Assessment: Assesses models using multiple performance metrics: predictability, stability, flexibility, and computational efficiency.
  • Systematic Comparison Design: Performs 320 comparisons across 20 methods and 16 datasets.
  • Real-World Variability Analysis: Highlights variability in model performance across datasets and metrics relevant to translational scientists and clinicians.
  • Guidance for Future Research: Identifies areas for further investigation in survival analysis techniques and benchmarking strategies.

Scientific Applications:

  • Translational research: Supports integration of omics and clinical data to select prognostic models for personalized treatment strategies.
  • Method selection and benchmarking: Provides comparative evidence to guide selection of appropriate survival models for specific datasets and study goals.

Methodology:

Benchmarks 20 methods across 16 datasets with 320 systematic comparisons, evaluating each model using multiple metrics (predictability, stability, flexibility, computational efficiency) and including Cox and machine-learning–based survival models.

Topics

Details

License:
Apache-2.0
Cost:
Free of charge
Tool Type:
library
Operating Systems:
Mac, Linux, Windows
Programming Languages:
R
Added:
9/28/2022
Last Updated:
11/24/2024

Operations

Publications

Zhang Y, Wong G, Mann G, Muller S, Yang JYH. SurvBenchmark: comprehensive benchmarking study of survival analysis methods using both omics data and clinical data. GigaScience. 2022;11. doi:10.1093/gigascience/giac071. PMID:35906887. PMCID:PMC9338425.

PMID: 35906887
PMCID: PMC9338425
Funding: - Australian Research Council: DP210100521 - National Health and Medical Research Council's CRE: APP1135285